Condition
Melanoma Stage
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown1
Recruiting1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06643286Not ApplicableRecruiting
Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
NCT03224208Phase 2Terminated
Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
NCT03449615UnknownPrimary
Validation of Ferromagnetic Tracer in Melanoma Sentinel Node
Showing all 3 trials